{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:53:41Z","timestamp":1762642421266,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004801","name":"Shota Rustaveli National Science Foundation","doi-asserted-by":"publisher","award":["FR\/510\/8-335\/14","PhD_F_17_189"],"award-info":[{"award-number":["FR\/510\/8-335\/14","PhD_F_17_189"]}],"id":[{"id":"10.13039\/501100004801","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Knowledge Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s11033-020-05863-z","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T09:03:08Z","timestamp":1601629388000},"page":"8331-8337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Low-dose trans-resveratrol induce poly(ADP)-ribosylation-dependent increase of the PPAR-\u03b3 protein expression level in the in vitro model of non-alcoholic fatty liver disease"],"prefix":"10.1007","volume":"47","author":[{"given":"Tinatin","family":"Kachlishvili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Ksovreli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Gabruashvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Museridze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marine","family":"Bezhuashvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgi","family":"Zaalishvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4570-0732","authenticated-orcid":false,"given":"Nina","family":"Kulikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,2]]},"reference":[{"issue":"4","key":"5863_CR1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ijge.2013.03.008","volume":"7","author":"HY Cheng","year":"2013","unstructured":"Cheng HY, Wang HY, Chang WH, Lin SC, Chu CH, Wang TE, Liu CC, Shih SC (2013) Nonalcoholic fatty liver disease: prevalence, influence on age and sex, and relationship with metabolic syndrome and insulin resistance. Int J Gerontol 7(4):194\u2013198. https:\/\/doi.org\/10.1016\/j.ijge.2013.03.008","journal-title":"Int J Gerontol"},{"issue":"1","key":"5863_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E (2018) Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15(1):11\u201320. https:\/\/doi.org\/10.1038\/nrgastro.2017.109","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"5863_CR3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","volume":"11","author":"T Hardy","year":"2016","unstructured":"Hardy T, Oakley F, Anstee QM, Day CP (2016) Nonalcoholic fatty liver disease: pathogenesis and disease spectrum. Annu Rev Pathol 11(1):451\u2013496. https:\/\/doi.org\/10.1146\/annurev-pathol-012615-044224","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"5863_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/17512433.2017.1300059","volume":"10","author":"S Cernea","year":"2017","unstructured":"Cernea S, Cahn A, Raz I (2017) Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetes. Expert Rev Clin Pharmacol 10(5):535\u2013547. https:\/\/doi.org\/10.1080\/17512433.2017.1300059","journal-title":"Expert Rev Clin Pharmacol"},{"key":"5863_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrd2060","volume":"5","author":"JA Baur","year":"2006","unstructured":"Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493\u2013506. https:\/\/doi.org\/10.1038\/nrd2060","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"5863_CR6","doi-asserted-by":"publisher","first-page":"e2264","DOI":"10.1371\/journal.pone.0002264","volume":"3","author":"JL Barger","year":"2008","unstructured":"Barger JL, Kayo T, Vann JM, Arias EB, Wang J, Hacker TA, Wang Y, Raederstorff D, Morrow JD, Leeuwenburgh C, Allison DB, Saupe KW, Cartee GD, Weindruch R, Prolla TA (2008) A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS ONE 3(6):e2264. https:\/\/doi.org\/10.1371\/journal.pone.0002264","journal-title":"PLoS ONE"},{"key":"5863_CR7","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3390\/nu9111201","volume":"9","author":"GFS Fernandes","year":"2017","unstructured":"Fernandes GFS, Silva GDB, Pavan AR, Chiba DE, Chin CM (2017) Epigenetic regulatory mechanisms induced by resveratrol. Nutrients 9:1201. https:\/\/doi.org\/10.3390\/nu9111201","journal-title":"Nutrients"},{"issue":"4","key":"5863_CR8","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1124\/mol.109.058479","volume":"76","author":"SM Shin","year":"2009","unstructured":"Shin SM, Cho IJ, Kim SG (2009) Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3 inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway. Mol Pharmacol 76(4):884\u2013895. https:\/\/doi.org\/10.1124\/mol.109.058479","journal-title":"Mol Pharmacol"},{"issue":"7543","key":"5863_CR9","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature14028","volume":"519","author":"M Sajish","year":"2015","unstructured":"Sajish M, Schimmel P (2015) A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol. Nature 519(7543):370\u2013373. https:\/\/doi.org\/10.1038\/nature14028","journal-title":"Nature"},{"key":"5863_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3109\/10641963.2015.1131288","volume":"38","author":"M Hu","year":"2016","unstructured":"Hu M, Liu B (2016) Resveratrol via activation of LKB1-AMPK signaling suppresses oxidative stress to prevent endothelial dysfunction in diabetic mice. Clin Exp Hypertens 38:381\u2013387. https:\/\/doi.org\/10.3109\/10641963.2015.1131288","journal-title":"Clin Exp Hypertens"},{"key":"5863_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/1028415X.2017.1284361","volume":"21","author":"N Pineda-ram\u00edrez","year":"2017","unstructured":"Pineda-ram\u00edrez N, Aguilar GFG, Espinoza-Rogo M, Aguilera P (2017) Current evidence for AMPK activation involvement on resveratrol-induced neuroprotection in cerebral ischemia. Nutr Neurosci 21:229\u2013247. https:\/\/doi.org\/10.1080\/1028415X.2017.1284361","journal-title":"Nutr Neurosci"},{"key":"5863_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3390\/nu9070751","volume":"9","author":"F Lan","year":"2017","unstructured":"Lan F, Weikel KA, Cacicedo JM, Ido Y (2017) Resveratrol-induced AMP-activated protein kinase activation is cell-type dependent: lessons from basic research for clinical application. Nutrients 9:751. https:\/\/doi.org\/10.3390\/nu9070751","journal-title":"Nutrients"},{"key":"5863_CR13","doi-asserted-by":"publisher","first-page":"984578","DOI":"10.1155\/2015\/984578","volume":"2015","author":"N Duarte","year":"2015","unstructured":"Duarte N, Coelho IC, Patarr\u00e3o RS, Almeida JI, Penha-Gon\u00e7alves C, Macedo MP (2015) How inflammation impinges on NAFLD: A role for Kupffer cells. Biomed Res Int 2015:984578. https:\/\/doi.org\/10.1155\/2015\/984578","journal-title":"Biomed Res Int"},{"key":"5863_CR14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.bbamcr.2012.12.003","volume":"1833","author":"P Lakatos","year":"2013","unstructured":"Lakatos P, Szab\u00f3 \u00c9, Heged C, Hask\u00f3 G, Gergely P, Bai P, Vir\u00e1g L (2013) 3-Aminobenzamide protects primary human keratinocytes from UV-induced cell death by a poly ( ADP-ribosyl) ation independent mechanism. Biochim Biophys Acta 1833:743\u2013751. https:\/\/doi.org\/10.1016\/j.bbamcr.2012.12.003","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"5863_CR15","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1083\/jcb.100.3.965","volume":"100","author":"P Greenspan","year":"1985","unstructured":"Greenspan P, Mayer EP, Fowler SD (1985) Nile red: a selective fluorescent stain for intracellular lipid droplets. J Cell Biol 100(3):965\u2013973. https:\/\/doi.org\/10.1083\/jcb.100.3.965","journal-title":"J Cell Biol"},{"key":"5863_CR16","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1172\/jci200114006","volume":"108","author":"M Febbraio","year":"2001","unstructured":"Febbraio M, Hajjar D, Silverstein R (2001) CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108:785\u2013791. https:\/\/doi.org\/10.1172\/jci200114006","journal-title":"J Clin Invest"},{"key":"5863_CR17","doi-asserted-by":"publisher","first-page":"44612","DOI":"10.1038\/srep44612","volume":"7","author":"W Luo","year":"2017","unstructured":"Luo W, Xu Q, Wang Q, Wu H, Hua J (2017) Effect of modulation of PPAR- \u03b3 activity on Kupffer cells M1\/M2 polarization in the development of non-alcoholic fatty liver disease. Sci Rep 7:44612. https:\/\/doi.org\/10.1038\/srep44612","journal-title":"Sci Rep"},{"key":"5863_CR18","doi-asserted-by":"publisher","first-page":"E8352","DOI":"10.1073\/pnas.1706945114","volume":"114","author":"J Fang","year":"2017","unstructured":"Fang J, Ianni A, Smolka C, Vakhrusheva O, Nolte H, Kr\u00fcger M (2017) Sirt7 promotes adipogenesis in the mouse by inhibiting autocatalytic activation of Sirt1. Proc Natl Acad Sci U S A 114:E8352\u2013E8361. https:\/\/doi.org\/10.1073\/pnas.1706945114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6993","key":"5863_CR19","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nature02583.Sirt1","volume":"429","author":"F Picard","year":"2004","unstructured":"Picard F, Kurtev M, Chung N, Topark-ngarm A, De ORM, Leid M, Mcburney MW (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-\u03b3. Nature 429(6993):771\u2013776. https:\/\/doi.org\/10.1038\/nature02583.Sirt1","journal-title":"Nature"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05863-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-020-05863-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05863-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T01:40:28Z","timestamp":1633138828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-020-05863-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["5863"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05863-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"8 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of\u00a0interest"}}]}}